[go: up one dir, main page]

PE20030837A1 - Tensioactivos pulmonares que contienen una polimixina para mejorar las propiedades superficiales - Google Patents

Tensioactivos pulmonares que contienen una polimixina para mejorar las propiedades superficiales

Info

Publication number
PE20030837A1
PE20030837A1 PE2003000203A PE2003000203A PE20030837A1 PE 20030837 A1 PE20030837 A1 PE 20030837A1 PE 2003000203 A PE2003000203 A PE 2003000203A PE 2003000203 A PE2003000203 A PE 2003000203A PE 20030837 A1 PE20030837 A1 PE 20030837A1
Authority
PE
Peru
Prior art keywords
treatment
polymixin
surface properties
improve surface
surfactants containing
Prior art date
Application number
PE2003000203A
Other languages
English (en)
Inventor
Jan Johansson
Tore Curstedt
Bengt Robertson
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27675681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20030837(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of PE20030837A1 publication Critical patent/PE20030837A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42Respiratory system, e.g. lungs, bronchi or lung cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA, QUE COMPRENDE: A)UN TENSIOACTIVO NATURAL MODIFICADO O TENSIOACTIVOS RECONSTITUIDOS/ARTIFICIALES, SELECCIONADOS DE: SURVANTA, INFASURF, ALVEOFACT O CUROSURFT, EFECTIVO EN EL TRATAMIENTO DE UN DESORDEN PULMONAR CAUSADO POR LA FALTA O DEFICIENCIA DE TENSIOACTIVO ENDOGENO; Y, B)0,1% A 10%, BASADA EN EL PESO DE (A), DE UNA POLIMIXINA. EL OBJETIVO DE LA ADICION DE LA POLIMIXINA ES INCREMENTAR LA RESISTENCIA A LA INACTIVACION DE LOS TENSIOACTIVOS NATURALES O RECONSTITUIDOS A FIN DE USARLOS EN EL TRATAMIENTO DE ENFERMEDADES PULMONARES TALES COMO SINDROMES DE DISTRES RESPIRATORIO ADULTO Y NEONATAL, SINDROME DE ASPIRACION DE MECONIO, NEUMONIA Y ENFERMEDADES PULMONARES CRONICAS
PE2003000203A 2002-03-01 2003-02-28 Tensioactivos pulmonares que contienen una polimixina para mejorar las propiedades superficiales PE20030837A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02004789A EP1340506B1 (en) 2002-03-01 2002-03-01 Compositions comprising pulmonary surfactants and a polymyxin having improved surface properties

Publications (1)

Publication Number Publication Date
PE20030837A1 true PE20030837A1 (es) 2003-11-21

Family

ID=27675681

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000203A PE20030837A1 (es) 2002-03-01 2003-02-28 Tensioactivos pulmonares que contienen una polimixina para mejorar las propiedades superficiales

Country Status (12)

Country Link
US (2) US20050203008A1 (es)
EP (3) EP1752161A3 (es)
AR (1) AR038642A1 (es)
AT (1) ATE349223T1 (es)
AU (1) AU2003210361A1 (es)
DE (1) DE60217060T2 (es)
DK (1) DK1340506T3 (es)
ES (1) ES2278823T3 (es)
PE (1) PE20030837A1 (es)
PT (1) PT1340506E (es)
SI (1) SI1340506T1 (es)
WO (1) WO2003074070A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2057185T1 (sl) * 2006-08-11 2016-10-28 Northern Antibiotics Oy Derivati polimiksina in njihove uporabe
US8251876B2 (en) 2008-04-22 2012-08-28 Hill-Rom Services, Inc. Breathing exercise apparatus
MX2011012531A (es) * 2009-05-25 2011-12-16 Chiesi Farma Spa Combinacion terapeutica que comprende un tensioactivo pulmonar y un esteroide.
US9180271B2 (en) 2012-03-05 2015-11-10 Hill-Rom Services Pte. Ltd. Respiratory therapy device having standard and oscillatory PEP with nebulizer
CA2949328C (en) 2014-07-09 2023-01-31 Xellia Pharmaceuticals Aps Low substituted polymyxins and compositions thereof
JP6626890B2 (ja) 2014-10-03 2019-12-25 クセリア ファーマシューティカルズ エーピーエスXellia Pharmaceuticals ApS 吸入用デバイスおよび同デバイスに含有される水溶液
PL3200827T3 (pl) 2014-10-03 2020-12-14 Xellia Pharmaceuticals Aps Kompozycje
CN104721509A (zh) * 2015-04-05 2015-06-24 四川双鑫生物科技有限公司 一种治疗小儿病毒性肺炎的汤剂药物及制备方法
CN114159546B (zh) * 2021-12-20 2024-06-04 北京双鹤润创科技有限公司 新一代合成肺表面活性物质制剂及其临床应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180142B1 (en) * 1998-08-21 2001-01-30 The Regents Of The University Of California Reduction of surfactant inactivation in pulmonary surfactant therapy
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante

Also Published As

Publication number Publication date
AU2003210361A1 (en) 2003-09-16
EP1480667A1 (en) 2004-12-01
PT1340506E (pt) 2007-03-30
SI1340506T1 (sl) 2007-04-30
ATE349223T1 (de) 2007-01-15
EP1340506A1 (en) 2003-09-03
DE60217060D1 (de) 2007-02-08
EP1340506B1 (en) 2006-12-27
US20090170758A1 (en) 2009-07-02
AR038642A1 (es) 2005-01-19
DE60217060T2 (de) 2007-06-21
DK1340506T3 (da) 2007-05-07
US20050203008A1 (en) 2005-09-15
EP1752161A2 (en) 2007-02-14
EP1752161A3 (en) 2010-09-01
ES2278823T3 (es) 2007-08-16
WO2003074070A1 (en) 2003-09-12
EP1480667B1 (en) 2006-12-06

Similar Documents

Publication Publication Date Title
AR076973A1 (es) Composicion tensioactiva reconstituida mejorada que contiene analogos de la proteina tensioactiva b (sp-b) y de la proteina tensioactiva c (sp-c)
AR113422A2 (es) Agentes tensioactivos reconstituidos que tienen propiedades mejoradas
Haitsma et al. Surfactant therapy for acute lung injury/acute respiratory distress syndrome
PE20030837A1 (es) Tensioactivos pulmonares que contienen una polimixina para mejorar las propiedades superficiales
AR045312A1 (es) Metodo que comprende la administracion nasal de xilitol a un mamifero no humano
AR022578A1 (es) Peptidos artificiales que tienen actividad superficial y el uso de los mismos en la preparacion de un tensioactivo artificial
ECSP22076862A (es) Compuestos antivirales y métodos para la administración de los mismos
AR065704A1 (es) Composiciones y equipos para el tratamiento de la influenza
SV2004001415A (es) Composiciones farmaceuticas para el tratamiento de la diabetes mellitus de tipo ii
PA8744101A1 (es) Metodo de terapia combinada para el tratamiento de la infeccion por el virus de la hepatitis c y composiciones farmaceuticas para usar en dicha terapia
ES2004856T3 (es) Agente tensioactivo pulmonar natural, procedimiento de preparacion y composiciones farmaceuticas.
CY1106667T1 (el) Βελτιωμενα συνθετικα μιγματα λιπιδιων για την παρασκευη μιας ανασυγκροτημενης επιφανειοδραστικης ουσιας
EA201000161A1 (ru) Синтетические поверхностно-активные пептиды легких
AR093569A1 (es) Tensioactivos pulmonares reconstituidos
AR064269A1 (es) Formulaciones inhalantes de bisfosfonato y metodos para su utilizacion
Mendenhall et al. Films from lung washings as a mechanism model for lung injury by ozone
ATE547104T1 (de) Zusammensetzung enthaltend einen lungensurfactant und sildenafil zur behandlung von lungenerkrankungen
CO2020004244A2 (es) Métodos y composiciones para tratar enfermedades pulmonares crónicas
MX2022013195A (es) Uso de proteina surfactante d para tratar infecciones virales.
AR038042A1 (es) Metodos y composiciones para el tratamiento de patologias respiratorias
BR0307235A (pt) Composição para inalação
PE20040848A1 (es) Formulacion pulverulenta que contiene tiotropio destinada a la inhalacion
HN1999000140A (es) Un metodo para la prevencion del inicio del asma.
Yee et al. Neonatal Hyperoxia Produces Histologic Signs of Pulmonary Hypertension and Shortens Life-Span in Aging Mice.
AR124744A1 (es) AGENTE PARA USO EN LA INDUCCIÓN DE INMUNIDAD ESPECÍFICA CONTRA EL VIRUS DEL SÍNDROME RESPIRATORIO SEVERO AGUDO SARS-CoV-2 EN SUJETOS MAYORES DE 60 AÑOS DE EDAD Y/O QUE TIENEN ENFERMEDADES CRÓNICAS (VARIANTES)

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed